Arrow Pharmaceuticals competitorsClear all

Arrow Pharmaceuticals's top competitors include Ultragenyx Pharmaceutical, Orphazyme, Lexicon Pharmaceuticals and CRISPR Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Arrow Pharmaceuticals
Arrow Pharmaceuticals
Arrow Pharmaceuticals is a company that specializes in provides pharmaceutical and genetic products.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Orphazyme
Orphazyme
Orphazyme develops therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
CRISPR Therapeutics
CRISPR Therapeutics
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Founding Date
Founding Date
2015
Founding Date
2010
Founding Date
2009
Founding Date
1995
Founding Date
2013
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cremorne, AU HQ
Locations
Novato, US HQ
Locations
København, DK HQ
Chicago, US
Newton, US
Locations
The Woodlands, US HQ
Jersey, JE
Atlanta, US
Birmingham, US
Boston, US
Charlotte, US
Chicago, US
see more
Locations
Zug, CH HQ
Greater London, GB
Cambridge, US
San Francisco, US
Employees
Employees
502% decrease
Employees
74021% increase
Employees
141
Employees
20216% increase
Employees
410
Valuation ($)
Valuation ($)
N/A
Valuation ($)
6.5 b
Valuation ($)
161.7 m
Valuation ($)
681.9 m
Valuation ($)
9 b
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.3 k
Twitter followers
254
Twitter followers
15.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
5
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
8
Average likes per tweet (last 30 days)
1.2
Average likes per tweet (last 30 days)
24.2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
83.33%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
260258
Alexa Website Rank
171455
Alexa Website Rank
497005
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
4.3
Employee Rating
5
Employee Rating
3.5
Employee Rating
3.6

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$271m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$322.1m (FY, 2019)
Revenue (est.)
$719k (FY, 2020)
Net income
Net income
N/A
Net income
($186.6m) (FY, 2020)
Net income
(kr633.2m) (FY, 2020)
Net income
$130.1m (FY, 2019)
Net income
($348.9m) (FY, 2020)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 200.1m
Total funding raised
$ 58.8m
Total funding raised
$ 244.7m
Total funding raised
$ 127m
For sources of this data, please see the company profile

View company profiles

Ultragenyx Pharmaceutical
HQ
Novato, US
Employees
740↑ 21% increase

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

View company
Orphazyme
HQ
København, DK
Employees
141

Orphazyme develops therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

View company
Lexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.

View company
CRISPR Therapeutics
HQ
Zug, CH
Employees
410

CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.

View company